J KEVIN BUCHI Insider Trading $ZIOP ZIOPHARM ONCOLOGY INC
Get free email notifications about insider trading for J KEVIN BUCHI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
Get the latest insider transactions of J KEVIN BUCHI. J KEVIN BUCHI is Chief Executive Officer in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Director in IMPAX LABORATORIES INC ($IPXL) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in STEMLINE THERAPEUTICS INC ($STML) and Director in Alexza Pharmaceuticals Inc. ($ALXA) and President & CEO in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Amneal Pharmaceuticals, Inc. ($AMRX).
Over the past year J KEVIN BUCHI has been an insider in 2 companies. The total value of shares held by J KEVIN BUCHI in these companies amounts to $27,919.
J KEVIN BUCHI ranks 26,674 out of 350,000 insiders. Go to Insider Ranking to see more.
J KEVIN BUCHI in ZIOPHARM ONCOLOGY INCTrading Symbol: ZIOP
Industry: PHARMACEUTICAL PREPARATIONS 
Position of J KEVIN BUCHI: Director
Holdings: 4,167 shares
Current Value: $27,919
Latest Transaction: May 06 2021
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70
Last 4 weeks trend: BUY
Last 3 months trend: BUY
Last 3 Months Overview:
Shares Bought: 4,167
Shares Sold: 0
Share Difference: +4,167
Value Difference: $0
Latest Insider Trading Transactions of J KEVIN BUCHI in ZIOPHARM ONCOLOGY INC
|1 Week||2 Weeks||1 Month||3 Months||6 Months||1 Year||2 Years|
|No. of Purchases||0||0||0||0||1||1||1|
|Value of Purchases ($)||0||0||0||0||0||0||0|
|No. of Sales||0||0||0||0||0||0||0|
|Value of Sales ($)||0||0||0||0||0||0||0|
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|May 06 2021||ZIOP||ZIOPHARM ONCOLOGY ...||BUCHI J KEVIN||Director||Option Exercise||A||4.31||31,250||134,688||31,250|
|May 06 2021||ZIOP||ZIOPHARM ONCOLOGY ...||BUCHI J KEVIN||Director||Grant||A||0.00||4,167||0||4,167||0 to 4.2 K|
|Oct 13 2020||ZIOP||ZIOPHARM ONCOLOGY ...||BUCHI J KEVIN||Director||Option Exercise||A||2.76||146,190||403,484||146,190|